Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Drug Discrimination in Methadone-Maintained Humans Study 1 (OMDD1)
This study is currently recruiting participants.
Study NCT00593463 Information provided by National Institute on Drug Abuse (NIDA)
First Received: January 4, 2008 Last Updated: May 28, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Drug Dependence
Additional conditions recognized in this trial
Substance-Related Disorders
More general conditions related to this trial
Disorders of Environmental Origin
Mental Disorders
Interventions listed in this trial
Cycloserine
Diltiazem
Gabapentin
Isradipine
Naloxone
Nifedipine
Placebo
Saline
Verapamil
Additional drug interventions recognized in this trial
Methadone
More general drug interventions related to this trial
Analgesics
Analgesics, Opioid
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Anti-Bacterial Agents
Anti-Dyskinesia Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Antibiotics, Antitubercular
Anticonvulsants
Antihypertensive Agents
Antimanic Agents
Antimetabolites
Antiparkinson Agents
Antitubercular Agents
Antitussive Agents
Calcium Channel Blockers
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Narcotic Antagonists
Narcotics
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Renal Agents
Reproductive Control Agents
Respiratory System Agents
Sensory System Agents
Therapeutic Uses
Tocolytic Agents
Tranquilizing Agents
Vasodilator Agents
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)
University of Arkansas
Back to top of Main Content
